First Light Acquisition Group, Inc. (NYSE:FLAG) announced in an 8-K this morning that it has brought additional funding to its combination with Calidi Therapeutics through a non-redemption agreement, forward purchase agreement (FPA) and PIPE.
The FPA is potentially the largest of these moves, covering up to 660,000 shares with investment from Great Point Capital, Funicular Funds and Marybeth Wooton. These investors have also agreed to purchase 45,714 shares for $5.25 per share through the PIPE, bringing in about $240,000 for the company.
As a third move, the trio will not redeem 205,714 shares and will be paid $1.08 million for opting to do so. This amount is equal to half of those shares’ value at First Light’s redemption price.
The SPAC has already secured shareholder approval for its $335 million combination combination with Calidi, which it initially announced in January. La Jolla, California-based Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that delivers oncolytic viruses for targeted therapy against difficult-to-treat cancers.
Earlier this week, First Light announced it had come to a similar FPA and non-redemption agreement with Meteora Capital Partners, which would cover up to 340,000 shares and protect 129,524 from redemption. All of these FPA’s cap the respective investors’ shareholdings at 9.9% of the total float, but having a larger number of overall investors likely helps raise the floor in terms of shares First Light can include.
Like Meteora, these new investors have also also directed capital towards the combined company’s Calidi Cure subsidiary. Overall, the company has now raised $1.98 million through the sale of Series B preferred shares in Calidi Cure in parallel to these other efforts.


FIGX Acquisition Corp. (NASDAQ:FIGXU) announced the pricing of its $131 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FIGXU”, Friday, June 27, 2025. The new SPAC aims to seek out a financial services target with a particular focus on wealth and asset managers with the potential to...
Yorkville Acquisition Corp. (NASDAQ:YORKU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “YORKU”, Friday, June 27, 2025. The new SPAC plans to combine with a target company in the telecom, media or technology sectors. Yorkville Acquisition Corp.’s management team is led...
At the SPAC of Dawn As pressure on Fed Chairman Jerome Powell increases, the market is set to ingest a raft of new indicators today as well as hear from Cleveland Fed President Beth Hammack on the potential interest rate path. Today will also see June’s 8th SPAC IPO as Cantor Equity Partners III Inc....
Cantor Equity Partners III Inc. (NASDAQ:CAEP) announced the pricing of its upsized $240 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CAEP”, Thursday, June 26, 2025. The new SPAC plans to combine with a target company in an industry where its management has relevant expertise such financial...
Launch One (NASDAQ:LPAA) has entered into a definitive agreement to combine with biotech firm Minovia Therapeutics at a $180 million pre-money valuation. Haifa, Israel-based Minovia is developing a drug platform based on mitochondrial cell therapies to potentially treat rare disorders as well as the effects of aging and other causes of bodily degeneration. The combined...